Lupin gets USFDA nod to market Wilson disease treatment drug
Lupin gets USFDA nod to market Wilson disease treatment drug

Lupin gets USFDA nod to market Wilson disease treatment drug

Anthony Fernandes Article rating: 5.0

Pharma major Lupin Limited announced on Friday that United States Food and Drug Administration (USFDA) had given the company approval for its Trientine Hydrochloride capsules USP, 250 mg. The company will now be able to market a generic equivalent of Syprine capsules, 250 mg of Bausch Health US, LLC.

How to evaluate your portfolio risk
How to evaluate your portfolio risk

How to evaluate your portfolio risk

Shashikant Singh Article rating: 3.8

There are different measures to assess the risk of your portfolio, which will help you to set your expectation right, with regard to your investment, in terms of risk and return.

Intellect Design gains on CBX FX launch
Intellect Design gains on CBX FX launch

Intellect Design gains on CBX FX launch

Geyatee Deshpande Article rating: 3.9

Intellect Design Arena announced the launch of CBX FX, which provides contextual FX trading experience to the bank’s corporate customers for managing hedging strategies.

Maruti Suzuki gains on launch of new offer
Maruti Suzuki gains on launch of new offer

Maruti Suzuki gains on launch of new offer

Geyatee Deshpande Article rating: 4.6

Maruti Suzuki in partnership with Cholamandalam Investment and Finance Company Limited (CIFCL) introduces ‘buy now pay later offer’ thereby, allowing customers to start making EMI payments after 60 days of loan disbursement.

Quick Heal invests Rs 2 crore in Singapore start-up
Quick Heal invests Rs 2 crore in Singapore start-up

Quick Heal invests Rs 2 crore in Singapore start-up

Apurva Joshi Article rating: 5.0

Quick Heal Technologies Limited has made a strategic investment of Rs 2 crore in Singapore-based start-up namely, Ray Pte Ltd, which specialises in the next generation networking and wireless technology.

Markets fail to benefit from rate cuts; slow economy fear surfaces
Markets fail to benefit from rate cuts; slow economy fear surfaces

Markets fail to benefit from rate cuts; slow economy fear surfaces

Pratik Shastri Article rating: 5.0

He added that the global economy is heading towards a recession and the value of global trade contracted to three per cent in Q1CY20. He also mentioned that the GDP growth in 2021 is likely to remain in negative.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 4.0

The market opened in the red on May 22, 2020. The previous trading session witnessed the Sensex going up  by 114.29 points to end at 30,932.90 and the Nifty was up 39.7 points to close at 9,106.25.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 3.9

The market opened in the red on May 22, 2020. The previous trading session witnessed the Sensex going up  by 114.29 points to end at 30,932.90 and the Nifty was up 39.7 points to close at 9,106.25.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.9

The market opened in the red on May 22, 2020, overall volumes in futures & options currently stand at 5,22 crore contracts with a turnover of Rs. 23,43,597.19 crore.

RSS
First22612262226322642266226822692270Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR